Hikma Pharmaceuticals USA INC Recalls

5 recalls on record in the United States

drugs: 5
drugs Class II
2026-05-06

Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx onl

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

View recall details →

drugs Class II
2026-09-02

Hikma Pharmaceuticals USA INC. recalls Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (N

Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

View recall details →

drugs Class II
2026-10-28

Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottle

Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

View recall details →

drugs Class II
2026-11-11

Hikma Pharmaceuticals USA INC. recalls Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only

CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.

View recall details →

drugs Class II
2026-11-11

Hikma Pharmaceuticals USA INC. recalls Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Onl

CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.

View recall details →